Pulmonary Fibrosis Research Enhancement Act
The source supplies the latest action, but no lifecycle stage.
Latest action (4 Aug 2010): Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
What this bill does
The Pulmonary Fibrosis Research Enhancement Act, introduced in the Senate, would direct the Secretary of Health and Human Services to establish a National Pulmonary Fibrosis Advisory Board and a National PF Registry. This registry would collect and store data on pulmonary fibrosis and related lung diseases, coordinating with existing federal, state, and local systems. The bill also requires the collection of information on factors potentially linked to the disease, such as environmental or occupational exposures, and makes this data available to the National Institutes of Health and the Department of Veterans Affairs.
Additionally, the bill mandates the development of a National Pulmonary Fibrosis Education and Awareness Plan. This plan would aim to increase public understanding of the disease, improve physician education for better diagnosis and treatment, and assess the financial and personal impact of pulmonary fibrosis on patients and families. The Director of the National Heart, Lung, and Blood Institute would also be encouraged to expand and coordinate research efforts on pulmonary fibrosis.
This bill was introduced in the Senate on August 4, 2010, and has not advanced beyond that stage. If it were to move forward, it would require consideration and approval by committees, and then a vote by both the Senate and the House of Representatives before it could be sent to the President.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Official summary
Pulmonary Fibrosis Research Enhancement Act - Amends the Public Health Service Act to require the Secretary of Health and Human Services (HHS), acting through the Director of the Centers for Disease Control and Prevention (CDC), to: (1) establish the National Pulmonary Fibrosis Advisory Board; (2) develop a system to collect data on pulmonary fibrosis and other interstitial lung diseases; and (3) establish the National PF Registry.
Requires the Secretary, in developing the Registry, to: (1) expand and coordinate existing data and surveillance systems, surveys, registries, and other federal public health and environmental infrastructure; and (2) provide for research access to pulmonary fibrosis data.
Directs the Secretary to ensure that epidemiological and other types of information are made available to the National Institutes of Health (NIH) and the Department of Veterans Affairs (VA).
Requires the Director of CDC to prepare the National Pulmonary Fibrosis Education and Awareness Plan, which shall: (1) focus on strategies to increase public education and awareness of pulmonary fibrosis; (2) address the need for new physician education strategies to improve diagnosis and treatment standards; and (3) assess and monitor the costs of pulmonary fibrosis and its burden on patients and families.
Encourages the Director of the National Heart, Lung, and Blood Institute to expand, intensify, and coordinate Institute pulmonary fibrosis research activities.
Timeline
4 Aug 2010
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Common questions
- What does S. 3703 do?
- The Pulmonary Fibrosis Research Enhancement Act, introduced in the Senate, would direct the Secretary of Health and Human Services to establish a National Pulmonary Fibrosis Advisory Board and a National PF Registry. This registry would collect and store data on pulmonary fibrosis and related lung diseases, coordinating with existing federal, state, and local systems. The bill also requires the collection of information on factors potentially linked to the disease, such as environmental or occupational exposures, and makes this data available to the National Institutes of Health and the Department of Veterans Affairs. Additionally, the bill mandates the development of a National Pulmonary Fibrosis Education and Awareness Plan. This plan would aim to increase public understanding of the disease, improve physician education for better diagnosis and treatment, and assess the financial and personal impact of pulmonary fibrosis on patients and families. The Director of the National Heart, Lung, and Blood Institute would also be encouraged to expand and coordinate research efforts on pulmonary fibrosis. This bill was introduced in the Senate on August 4, 2010, and has not advanced beyond that stage. If it were to move forward, it would require consideration and approval by committees, and then a vote by both the Senate and the House of Representatives before it could be sent to the President.
- Has S. 3703 become law?
- The source does not supply a confirmed lifecycle stage for S. 3703. Check the latest action and official source below.
- Who sponsored S. 3703?
- S. 3703 was sponsored by Sen. Murray, Patty [D-WA] (D-WA), with 7 cosponsors.
- What's the latest action on S. 3703?
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (4 Aug 2010).
Related bills in Health
Choices for Increased Mobility Act of 2026
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Access to Medical Supplies Act
Lower Premiums, Faster Payments Act
More bills from Sen. Murray, Patty [D-WA]
Affordability is Access Act of 2026
Zeus 95 Memorial Act
Jeanette Acosta Invest in Women’s Health Act of 2026
Defense Community Infrastructure Program Tribal Eligibility Act of 2026
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.